Center of Biomedical Research Excellence, Epigenomics of Development and Disease

Information

  • Research Project
  • 10204026
  • ApplicationId
    10204026
  • Core Project Number
    P20GM104360
  • Full Project Number
    5P20GM104360-08
  • Serial Number
    104360
  • FOA Number
    PAR-18-264
  • Sub Project Id
  • Project Start Date
    9/10/2013 - 11 years ago
  • Project End Date
    6/30/2024 - 6 months ago
  • Program Officer Name
    FRINCU, CRINA
  • Budget Start Date
    7/1/2021 - 3 years ago
  • Budget End Date
    6/30/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    08
  • Suffix
  • Award Notice Date
    7/9/2021 - 3 years ago

Center of Biomedical Research Excellence, Epigenomics of Development and Disease

UNIVERSITY OF NORTH DAKOTA EPIGENOMICS OF DEVELOPMENT AND DISEASE OVERALL PROJECT SUMMARY The goal of this COBRE II application is to expand and enhance research into epigenetic mechanisms underlying development and disease at the University of North Dakota by providing ongoing support to the Epigenetics Working Group (EWG). In COBRE I the EWG made significant progress towards development of an epigenetics/epigenomics program through support of individual projects; recruitment of epigenetics experts to our group and supporting faculty development through mentoring programs. We established a comprehensive Genomics Core to meet the needs of the epigenetics community and provided technical and financial support that increased the number of researchers in our community utilizing epigenetic approaches. In Phase I our COBRE Investigators made important discoveries that resulted in 253 papers published in high impact journals, 66 poster and oral presentations by Project Leaders at invited seminars or scientific meetings, and the awarding of more than $10.8 million in external funding primarily from R01, R21, and NSF grants. Here we seek to maintain this momentum through continuation and expansion of these programs via the following strategies: We will recruit faculty with interests and expertise that increase the size of our group and extend our competencies into mechanistic and translational areas; We will enhance the offerings of the Genomics Core to further increase the ability of our group to perform high-quality research; We will enhance the ability of our investigators to transition to independent funding through support of individual projects and scientific and faculty development mentoring programs. Our long-term goal is to transition the EWG into a sustainable scientific center dedicated to understanding molecular mechanisms of developmental and pathological disorders that will attract top talent, train the next generation of scientists, and become a regional hub for cutting edge epigenetics research. ! ! !

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P20
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
    1458167
  • Indirect Cost Amount
    568685
  • Total Cost
    2026852
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
    NIGMS:2026852\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZGM1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    UNIVERSITY OF NORTH DAKOTA
  • Organization Department
    PHARMACOLOGY
  • Organization DUNS
    102280781
  • Organization City
    GRAND FORKS
  • Organization State
    ND
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    582027306
  • Organization District
    UNITED STATES